Yoshida receives prestigious FAER Research Fellowship Grant to investigate immune-driven chronic pain
Fourth-year anesthesiology resident Mitsukuni Yoshida, MD, PhD, was recently awarded a $75,000 Research Fellowship Grant from the Foundation for Anesthesia Education and Research (FAER).
Dr. Bernadette Henrichs appointed dean of Goldfarb School of Nursing (Links to an external site)
Barnes-Jewish College Goldfarb School of Nursing has announced the appointment of Bernadette Henrichs, PhD, CRNA, CCRN, CHSE, FAANA, FAAN, as its new dean, effective mid-June 2025.
Drewry and Durko complete inaugural Pivotal Leaders Program at WashU Medicine
Drs. Drewry & Durko completed the inaugural Pivotal Leaders Program for Division Chiefs and Section Heads at WashU Medicine on May 8, 2025.
Farewell to our chief residents: celebrating leadership, growth, and new beginnings
As graduation day approaches, our three chief residents reflect on their experiences, share what’s next in their careers, and offer advice to those following in their footsteps.
McKinney named recipient of 2025 WashU Medicine Dean’s Distinguished Service Award
Kenya McKinney, CRNA, has been selected as a recipient of the 2025 Dean’s Distinguished Service Award.
15 WashU anesthesiology residents present at MARC 2025
Residents from the Department of Anesthesiology at WashU Medicine presented their research and case reports at the 2025 Midwest Anesthesia Resident Conference (MARC), held April 25–27 in Indianapolis.
Goodin receives 2025 Outstanding Faculty Mentor Award
The Office of Postdoctoral Affairs at WashU Medicine has selected Burel Goodin, PhD, professor of anesthesiology, as the recipient of the 2025 Outstanding Faculty Mentor Award.
Anesthesiology Resident’s Study on Post-Surgery Outcomes Published in JAMA Surgery
Roberta Teixeira Tallarico, MB, a first-year anesthesiology resident, recently had her T32 Research Fellowship project published in JAMA Surgery on April 30, 2025. Her study, “Postoperative Outcomes Among Sodium-Glucose Cotransporter 2 Inhibitor Users,” explores how a newer type of medication, called sodium-glucose cotransporter 2 inhibitors (SGLT2i), may influence surgical recovery.







